MedTrace Logo

L-Gastrectomy With the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System

NCT04526483 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2020-08-25

No results posted yet for this study

Summary

This study aims to evaluate the safety, efficacy, and feasibility of the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System in patients with gastric cancer.

Conditions

  • Stomach Neoplasms

Interventions

DEVICE

Laparoscopic gastrectomy with Intelligent Navigation 4K UHD 3D Endoscopic Imaging System

Laparoscopic gastrectomy with Intelligent Navigation 4K UHD 3D Endoscopic Imaging System

Sponsors & Collaborators

  • Shanghai Minimally Invasive Surgery Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-10-01
Completion
2022-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04526483 on ClinicalTrials.gov